A prior settlement was reached in 2014 which was available to victims who underwent a revision surgery before November 2014. Thousands of claimants participated in this settlement and Stryker paid more than $1 billion in benefits. But victims who had to undergo a revision surgery after November 2014 were not eligible to participate in the prior settlement.
The newly negotiated settlement allows eligible victims to participate in this settlement if they underwent a revision surgery to remove their Rejuvenate and ABG II modular femoral stems on or before December 19, 2016.
Eligible victims who choose to participate in the settlement can receive a base award of up to $300,000 for each hip that underwent a revision surgery.
Brian Devine, an attorney who represents patients with the Stryker Rejuvenate and ABG II stems, said "We are pleased that Stryker has finally agreed to the latest round of settlements, which will provide compensation to the most recent victims of the poorly designed implant. We expect that most of the settlement payments for this round of settlement will be disbursed by the end of 2017."
Stryker recalled its Rejuvenate and ABG II modular stems in 2012 after about 20,000 Americans had them implanted in their bodies. Many of these implants have corroded at the junction between the stem and the neck, which has led to painful, complex, and risky surgeries to remove and replace the stem.